$MBCN
MIDDLEFIELD BANC CORP Stock $mbcn

$mbcn Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000143774920009578 Filed on May 06, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019 Q1
Revenue	$13.01M	$13.44M	$13.48M
YoY Change	-3.52%	-0.17%	12.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$630.0K	$600.0K	$560.0K
YoY Change	12.5%	22.45%	75.0%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$2.976M	$3.128M	$3.254M
YoY Change	-8.54%	4.34%	59.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$1.115M	$3.775M	$3.622M
YoY Change	-69.22%	-5.27%	15.61%
Income Tax	$74.00K	$634.0K	$611.0K
% Of Pretax Income	6.64%	16.79%	16.87%
Net Earnings	$1.041M	$3.141M	$3.011M
YoY Change	-65.43%	-8.29%	15.59%
Net Earnings / Revenue	8.0%	23.38%	22.33%
Basic Earnings Per Share	$0.16	$0.48	$0.46
Diluted Earnings Per Share	$0.16	$0.48	$0.46
COMMON SHARES
Basic Shares Outstanding	6.417M	6.424M	6.498M
Diluted Shares Outstanding	6.429M	6.455M	6.511M

Balance Sheet

Concept	2020 Q1	2019 Q4	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$55.33M	$35.11M	$121.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$17.65M	$17.87M	$15.74M
YoY Change	12.15%	37.46%	28.76%
Goodwill	$15.07M	$15.10M	$15.07M
YoY Change	0.0%	0.19%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.214B	$1.182B	$1.281B
YoY Change	-5.23%	-5.28%	15.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.900M	$5.100M	$4.400M
YoY Change	11.36%	6.25%	2.33%
Accrued Expenses	$0.00	$900.0K	$2.100M
YoY Change	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$60.00M	$5.075M	$91.00M
YoY Change	-34.07%	-94.39%	387.39%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.900M	$900.0K	$2.100M
YoY Change	133.33%	-99.0%	-88.77%
LONG-TERM LIABILITIES
Long-Term Debt	$12.70M	$12.30M	$11.50M
YoY Change	10.43%	39.77%	-39.47%
Other Long-Term Liabilities	$4.900M	$5.100M	$4.400M
YoY Change	11.36%	6.25%	2.33%
Total Long-Term Liabilities	$17.60M	$17.40M	$15.90M
YoY Change	10.69%	27.94%	-31.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.900M	$900.0K	$2.100M
Total Long-Term Liabilities	$17.60M	$17.40M	$15.90M
Total Liabilities	$1.081B	$1.045B	$1.149B
YoY Change	-5.92%	-6.73%	16.48%
SHAREHOLDERS EQUITY
Retained Earnings	$65.14M	$65.06M	$58.14M
YoY Change	12.04%	16.11%	18.83%
Common Stock	$86.72M	$86.62M	$86.44M
YoY Change	0.33%	0.81%	1.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$16.94M	$15.75M	$13.52M
YoY Change	25.3%	16.49%	0.0%
Treasury Stock Shares	$929.4K	$871.2K	$772.3K
Shareholders Equity	$132.7M	$137.8M	$131.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.214B	$1.182B	$1.281B
YoY Change	-5.23%	-5.28%	15.74%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019 Q1
OPERATING ACTIVITIES
Net Income	$1.041M	$3.141M	$3.011M
YoY Change	-65.43%	-8.29%	15.59%
Depreciation, Depletion And Amortization	$630.0K	$600.0K	$560.0K
YoY Change	12.5%	22.45%	75.0%
Cash From Operating Activities	$2.980M	$3.750M	$681.0K
YoY Change	337.59%	-36.55%	-65.08%
INVESTING ACTIVITIES
Capital Expenditures	$184.0K	-$480.0K	$295.0K
YoY Change	-37.63%	84.62%	-51.08%
Acquisitions
YoY Change
Other Investing Activities	-$18.13M	$13.46M	-$11.27M
YoY Change	60.87%	-182.83%	52.71%
Cash From Investing Activities	-$18.31M	$12.99M	-$11.57M
YoY Change	58.3%	-178.68%	44.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.191M		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$35.55M	-101.7M	24.00M
YoY Change	48.14%	-377.88%	-4126.34%
NET CHANGE
Cash From Operating Activities	$2.980M	3.750M	681.0K
Cash From Investing Activities	-$18.31M	12.99M	-11.57M
Cash From Financing Activities	$35.55M	-101.7M	24.00M
Net Change In Cash	$20.22M	-84.91M	13.11M
YoY Change	54.21%	-426.83%	-297.83%
FREE CASH FLOW
Cash From Operating Activities	$2.980M	$3.750M	$681.0K
Capital Expenditures	$184.0K	-$480.0K	$295.0K
Free Cash Flow	$2.796M	$4.230M	$386.0K
YoY Change	624.35%	-31.44%	-71.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000836147
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6369467
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	Middlefield Banc Corp.
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, Without Par Value
CY2020Q1	dei	Trading Symbol TradingSymbol	mbcn
CY2020Q1	mbcn	Estimated Selling Costs Of Impaired Loans EstimatedSellingCostsOfImpairedLoans	2000000
CY2019	mbcn	Estimated Selling Costs Of Impaired Loans EstimatedSellingCostsOfImpairedLoans	2100000
CY2020Q1	mbcn	Finance Lease Assets Added To Premises And Equipment Noncash Investing Transactions FinanceLeaseAssetsAddedToPremisesAndEquipmentNoncashInvestingTransactions
CY2019Q1	mbcn	Finance Lease Assets Added To Premises And Equipment Noncash Investing Transactions FinanceLeaseAssetsAddedToPremisesAndEquipmentNoncashInvestingTransactions	2771000
CY2020Q1	mbcn	Finance Lease Liabilities Added To Borrowed Funds Noncash Financing Transactions FinanceLeaseLiabilitiesAddedToBorrowedFundsNoncashFinancingTransactions
CY2019Q1	mbcn	Finance Lease Liabilities Added To Borrowed Funds Noncash Financing Transactions FinanceLeaseLiabilitiesAddedToBorrowedFundsNoncashFinancingTransactions	2771000
CY2020Q1	mbcn	Gain Loss On Sales Of Loans Excluding Student Loans Net GainLossOnSalesOfLoansExcludingStudentLoansNet	114000
CY2019Q1	mbcn	Gain Loss On Sales Of Loans Excluding Student Loans Net GainLossOnSalesOfLoansExcludingStudentLoansNet	37000
CY2020Q1	mbcn	Number Of Days Past Due NumberOfDaysPastDue	P90D
CY2020Q1	mbcn	Ohio State Franchise Tax OhioStateFranchiseTax	268000
CY2019Q1	mbcn	Ohio State Franchise Tax OhioStateFranchiseTax	259000
CY2020Q1	mbcn	Operating Lease Assets Added To Other Net Noncash Operating Transaction OperatingLeaseAssetsAddedToOtherNetNoncashOperatingTransaction
CY2019Q1	mbcn	Operating Lease Assets Added To Other Net Noncash Operating Transaction OperatingLeaseAssetsAddedToOtherNetNoncashOperatingTransaction	2101000
CY2020Q1	mbcn	Operating Lease Liabilities Added To Other Net Noncash Operating Transaction OperatingLeaseLiabilitiesAddedToOtherNetNoncashOperatingTransaction
CY2019Q1	mbcn	Operating Lease Liabilities Added To Other Net Noncash Operating Transaction OperatingLeaseLiabilitiesAddedToOtherNetNoncashOperatingTransaction	2101000
CY2020Q1	mbcn	Percentage Of Portfolio PercentageOfPortfolio	0.96
CY2020Q1	mbcn	Proceeds From Dividend Reinvestment Purchase Plan ProceedsFromDividendReinvestmentPurchasePlan
CY2019Q1	mbcn	Proceeds From Dividend Reinvestment Purchase Plan ProceedsFromDividendReinvestmentPurchasePlan	196000
CY2020Q1	mbcn	Restrict Stock Cash RestrictStockCash
CY2019Q1	mbcn	Restrict Stock Cash RestrictStockCash	44000
CY2020Q1	mbcn	Revenue From Interest Income And Noninterest Income Percent RevenueFromInterestIncomeAndNoninterestIncomePercent	0.918
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	42000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	102959000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	105733000
CY2020Q1	mbcn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period For Stock And Cash SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodForStockAndCash	1000
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-84000
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-94000
CY2020Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	4880000
CY2019Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	6032000
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2237000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1842000
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-408000
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	90000
CY2020Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	244000
CY2019Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	55000
CY2020Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	508000
CY2019Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	517000
CY2020Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	255000
CY2019Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	259000
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83000
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	85000
CY2020Q1	us-gaap	Assets Assets	1213939000
CY2019Q4	us-gaap	Assets Assets	1182475000
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1007000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2466000
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3838000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	134000
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	105790000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	103401000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	17965000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	18255000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1316000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1328000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	86467000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	83334000
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	42000
CY2020Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	86
CY2020Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	16618000
CY2019Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	16511000
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	107000
CY2019Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	105000
CY2020Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	141000
CY2019Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	145000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35113000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107933000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55333000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121045000
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	20220000
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13112000
CY2020Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	53533000
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	35113000
CY2020Q1	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	55333000
CY2019Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	35113000
CY2020Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2019Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7298829
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7294792
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6369467
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6423630
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6512740
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	86722000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	86617000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3038000
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3806000
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	2539000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	8223000
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	14000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	107000
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	51663000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5733000
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3824000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	27000
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	54202000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	13956000
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3838000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	134000
CY2020Q1	us-gaap	Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent	287000
CY2019Q1	us-gaap	Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent	236000
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-308000
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	295000
CY2020Q1	us-gaap	Deposits Deposits	1003710000
CY2019Q4	us-gaap	Deposits Deposits	1020843000
CY2020Q1	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	156556000
CY2019Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	160826000
CY2020Q1	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	175468000
CY2019Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	192003000
CY2020Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	306000
CY2019Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	259000
CY2020Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	30000
CY2019Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	58000
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	964000
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	909000
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2020Q1	us-gaap	Equipment Expense EquipmentExpense	273000
CY2019Q1	us-gaap	Equipment Expense EquipmentExpense	235000
CY2020Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	550000
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	710000
CY2020Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2019Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-160000
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	58000
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	123000
CY2019Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	130000
CY2020Q1	us-gaap	Federal Funds Purchased And Securities Sold Under Agreements To Repurchase FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
CY2019Q4	us-gaap	Federal Funds Purchased And Securities Sold Under Agreements To Repurchase FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	75000
CY2020Q1	us-gaap	Federal Funds Sold FederalFundsSold	1800000
CY2019Q4	us-gaap	Federal Funds Sold FederalFundsSold
CY2020Q1	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate	60000000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate	5000000
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	99000
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	69000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	8028000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	6108000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1216000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	660000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	70000
CY2019	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	33000
CY2020Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	985114000
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	971188000
CY2020Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	12886000
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	13070000
CY2019Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2020Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	3600000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	1300000
CY2020Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2019Q1	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2020Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2019Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	981921000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	975566000
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	8405000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	8879000
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	16079000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	8692000
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1973000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2056000
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	114000
CY2019Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	59000
CY2020Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate
CY2019Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	43000
CY2020Q1	us-gaap	Goodwill Goodwill	15071000
CY2019Q4	us-gaap	Goodwill Goodwill	15071000
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	12979000
CY2019Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15025000
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	105000
CY2019Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	185000
CY2020Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	12886000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	13070000
CY2020Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1216000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	660000
CY2020Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	13741000
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	13986000
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	6129000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	7344000
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	6923000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	8199000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	6757000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	5726000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	6818000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	5787000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1115000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3622000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	611000
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	195000
CY2019Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	200000
CY2020Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-17133000
CY2019Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	24164000
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	63000
CY2019Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	192000
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1277000
CY2019Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2553000
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	12290
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	12334
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	666000
CY2019Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	465000
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13009000
CY2019Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	13484000
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12078000
CY2019Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12488000
CY2020Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	125184000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	107844000
CY2020Q1	us-gaap	Interest Expense InterestExpense	2976000
CY2019Q1	us-gaap	Interest Expense InterestExpense	3254000
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2865000
CY2019Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2945000
CY2020Q1	us-gaap	Interest Expense Other InterestExpenseOther	76000
CY2019Q1	us-gaap	Interest Expense Other InterestExpenseOther	96000
CY2020Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	35000
CY2019Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	213000
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	94000
CY2019Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	187000
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	7293000
CY2019Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	9990000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10033000
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10230000
CY2020Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	21000
CY2019Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	7000
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	629000
CY2019Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	565000
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	157000
CY2019Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	179000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	2913000
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	3062000
CY2020Q1	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	14513000
CY2019Q4	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	10697000
CY2020Q1	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	131000
CY2019Q1	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	138000
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3524000
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4124000
CY2020Q1	us-gaap	Liabilities Liabilities	1081252000
CY2019Q4	us-gaap	Liabilities Liabilities	1044700000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1213939000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1182475000
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9244000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	6768000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7428000
CY2019Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7206000
CY2020Q1	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	1300000
CY2019Q4	us-gaap	Loans And Leases Receivable Deferred Income LoansAndLeasesReceivableDeferredIncome	1300000
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	100000
CY2019	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	342000
CY2020Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	998000000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	984258000
CY2020Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	988756000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	977490000
CY2020Q1	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	513000
CY2019Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	1220000
CY2020Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	209000
CY2019Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	203000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35549000
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23997000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18309000
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11566000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2980000
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	681000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1041000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	3011000
CY2020Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	206372000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	191370000
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	7252000
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	7500000
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	1074000
CY2019Q1	us-gaap	Noninterest Income NoninterestIncome	1132000
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	329000
CY2019Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	264000
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	550000
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	553000
CY2020Q1	us-gaap	Other Borrowings OtherBorrowings	12662000
CY2019Q4	us-gaap	Other Borrowings OtherBorrowings	12750000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4079000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	795000
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-5163000
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1006000
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1084000
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	211000
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1066000
CY2019Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	870000
CY2020Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0
CY2019Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0
CY2020Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3232000
CY2019Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2556000
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	14052000
CY2019Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	12616000
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1191000
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	964000
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	909000
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5252000
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2679000
CY2020Q1	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock	1600000
CY2019Q1	us-gaap	Payments To Acquire Federal Home Loan Bank Stock PaymentsToAcquireFederalHomeLoanBankStock
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	184000
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	295000
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Reclassification of Comparative Amounts</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain comparative amounts for prior years have been reclassified to conform to current-year presentations. Such reclassifications did <div style="display: inline; font-style: italic; font: inherit;">not</div> affect net income or retained earnings.</div></div></div></div></div></div>
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2779000
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3799000
CY2020Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	54925000
CY2019Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	602000
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2020Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4053000
CY2019Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1960000
CY2020Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate
CY2019Q1	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	225000
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	349000
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	431000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17653000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17874000
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	2740000
CY2019Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	240000
CY2020Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	88000
CY2019Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	56000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	65140000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	65063000
CY2020Q1	us-gaap	Security Owned And Pledged As Collateral Fair Value SecurityOwnedAndPledgedAsCollateralFairValue	53100000
CY2019Q4	us-gaap	Security Owned And Pledged As Collateral Fair Value SecurityOwnedAndPledgedAsCollateralFairValue	55600000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	13500
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.78
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13500
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14900
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14500
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.78
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.78
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.78
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.78
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0
CY2020Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	60000000
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5075000
CY2019Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	196000
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105000
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	316000
CY2020Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	-302000
CY2019Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	186000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	132687000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	137775000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	128290000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	131699000
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2020Q1	us-gaap	Time Deposits TimeDeposits	340130000
CY2019Q4	us-gaap	Time Deposits TimeDeposits	368800000
CY2020Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	301000
CY2019Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	38000
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	929362
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	871162
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	772330
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	58200
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	16938000
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	15747000
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1191000
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6510568
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6429443
CY2019Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7270608
CY2020Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	7298740
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6498278
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6417109
CY2019Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	772330
CY2020Q1	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	881631

Files In Submission

Name	View Source	Status
0001437749-20-009578-index-headers.html	Edgar Link	pending
0001437749-20-009578-index.html	Edgar Link	pending
0001437749-20-009578.txt	Edgar Link	pending
0001437749-20-009578-xbrl.zip	Edgar Link	pending
ex_183695.htm	Edgar Link	pending
ex_183696.htm	Edgar Link	pending
ex_183697.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image0112.jpg	Edgar Link	pending
mbcn-20200331.xml	Edgar Link	completed
mbcn-20200331.xsd	Edgar Link	pending
mbcn-20200331_cal.xml	Edgar Link	unprocessable
mbcn-20200331_def.xml	Edgar Link	unprocessable
mbcn-20200331_lab.xml	Edgar Link	unprocessable
mbcn-20200331_pre.xml	Edgar Link	unprocessable
mbcn20200331_10q.htm	Edgar Link	pending
mbcn20200331_10qimg050.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MBCN
MIDDLEFIELD BANC CORP Stock $mbcn

2020 Q1 Form 10-Q Financial Statement

#000143774920009578 Filed on May 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MBCN MIDDLEFIELD BANC CORP Stock $mbcn

2020 Q1 Form 10-Q Financial Statement

#000143774920009578 Filed on May 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MBCN
MIDDLEFIELD BANC CORP Stock $mbcn